Search

Author/Creator Dimopoulos, M.A.

1. 2608 A retrospective study of vascular thromboembolic events (VaTEs) in patients receiving first line treatment for advanced urothelial cancer (AUC). (September 2015)

Authors:
Dimitriadis, I.; Tsironis, G.; Tzannis, K.; Koutsoukos, K.; Kostouros, E.; Liontos, M.; Lykka, M.; Trajce, E.; Nikolopoulos, K.; Sfika, A.; Kafantari, E.; Zagouri, F.; Matsouka, C.; Dimopoulos, M.A.; Bamias, A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S514
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (POLLUX). (June 2017)

Authors:
Bahlis, N.J.; Moreau, P.; Nahi, H.; Plesner, T.; Goldschmidt, H.; Suzuki, K.; Orlowski, R.Z.; Rabin, N.; Leiba, M.; Oriol, A.; Chari, A.; San Miguel, J.; Richardson, P.G.; Usmani, S.; O'Rourke, L.; Wu, K.; Casneuf, T.; Chiu, C.; Qin, X.; Dimopoulos, M.A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY. (12th June 2019)

Authors:
Tedeschi, A.; Dimopoulos, M.A.; Trotman, J.; García‐Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L.T.; Tam, C.S.; Varettoni, M.; Palomba, M.L.; Matous, J.V.; Shustik, C.; Kastritis, E.; Treon, S.P.; Li, J.; Poulsen, E.G.; Hauns, B.; Buske, C.; Leblond, V.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly diagnosed chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-associated Thrombosis. The Observational ROADMAP-CAT-MM Study. Issue 164 (April 2018)

Authors:
Fotiou, D.; Papageorgiou, L.; Salta, S.; Terpos, E.; Fareed, J.; VanDreden, P.; Lefkou, E.; Larsen, A.K.; Elalamy, I.; Dimopoulos, M.A.; Gerotziafas, G.T.
Journal:
Thrombosis research
Issue:
Issue 164(2018)Supplement 1
Page Start:
S235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The proteasome inhibitor carfilzomib (Cfz) induces cardiotoxicity in vivo: molecular mechanisms and the cardioprotective effect of metformin (Met). (July 2018)

Authors:
Kremastiotis, G.; Efentakis, P.; Varela, A.; Davos, C.H.; Tsoumani, M.; Papanagnou, E.D.; Trougakos, I.P.; Kastritis, E.; Kanaki, Z.; Iliodromitis, E.K.; Klinakis, A.; Dimopoulos, M.A.; Terpos, E.; Andreadou, I.
Journal:
Journal of molecular and cellular cardiology
Issue:
Volume 120(2018)Supplement
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗